CIMA has released the SCS pre-seen material for the November 2018 exam sitting. To get your copy of the pre-seen, check out my Home page. The preseen company is Novak Pharmaceuticals, which is a listed pharmaceutical company based in the country of Cronland.
NOW is an excellent time to kickstart your CIMA case study preparation.
Various analyses will aid you in understanding and decoding pre-seen jargons:
- Pre-seen analysis – An in-depth analysis of the pre-seen material. We look at our pre-seen company in detail. We learn about the company background, structure and financial standing.
- Strategic analysis – Hot on the heels of a pre-seen analysis is to do a strategic analysis to help us with perspective. We need to know where the company has been, where it is now and where it is headed.
- Most likely issues – Based on what has been mentioned (and sometimes, not mentioned) on the pre-seen material, we can gather clues to risks, issues, and events that may affect our fictitious company.
- Industry analysis – This puts our pre-seen company in the context of the real world. We look at some real-life examples of companies in the same industry. We highlight problems and circumstances that have made the news, and find out how these companies have dealt with them.
The above analyses are delivered in both written and video formats. If you are unsure about the resources available, check out what Astranti has to offer with regards all things SCS.
Good luck, student!